Met Life Investment Management, LLC Ocular Therapeutix, Inc Transaction History

Met Life Investment Management, LLC

  • $18 Billion
  • Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 92,734 shares of OCUL stock, worth $675,103. This represents 0.0% of its overall portfolio holdings.

Number of Shares
92,734
Previous 90,280 2.72%
Holding current value
$675,103
Previous $785,000 0.76%
% of portfolio
0.0%
Previous 0.0%

Shares

47 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$8.33 - $11.47 $20,441 - $28,147
2,454 Added 2.72%
92,734 $791,000
Q2 2024

Aug 13, 2024
BUY
$4.2 - $8.69 $129,977 - $268,929
30,947 Added 52.16%
90,280 $617,000
Q1 2024

May 14, 2024
BUY
$3.85 - $10.93 $228,432 - $648,509
59,333 New
59,333 $539,000
Q2 2023

Apr 29, 2024
BUY
$4.6 - $7.64 $186,980 - $310,550
40,648 New
40,648 $209,000
Q1 2023

May 09, 2024
BUY
$2.79 - $6.27 $113,407 - $254,862
40,648 New
40,648 $214 Million
Q1 2023

May 15, 2023
BUY
$2.79 - $6.27 $38,437 - $86,381
13,777 Added 51.27%
40,648 $214,000
Q4 2022

May 10, 2024
SELL
$2.61 - $4.41 $36,568 - $61,788
-14,011 Reduced 34.27%
26,871 $75,000
Q4 2022

Jun 14, 2023
SELL
$2.61 - $4.41 $35,957 - $60,756
-13,777 Reduced 33.89%
26,871 $75,000
Q4 2022

Mar 22, 2023
SELL
$2.61 - $4.41 $36,568 - $61,788
-14,011 Reduced 34.27%
26,871 $75,000
Q4 2022

Feb 15, 2023
SELL
$2.61 - $4.41 $36,568 - $61,788
-14,011 Reduced 34.27%
26,871 $75,000
Q3 2022

Jun 14, 2023
BUY
$4.09 - $6.5 $957 - $1,521
234 Added 0.58%
40,882 $169,000
Q2 2022

May 10, 2024
BUY
$3.01 - $5.22 $54,083 - $93,792
17,968 Added 78.41%
40,882 $164,000
Q2 2022

Jun 20, 2023
BUY
$3.01 - $5.22 $704 - $1,221
234 Added 0.58%
40,882 $164,000
Q2 2022

Mar 22, 2023
BUY
$3.01 - $5.22 $54,083 - $93,792
17,968 Added 78.41%
40,882 $164,000
Q2 2022

Aug 11, 2022
BUY
$3.01 - $5.22 $54,083 - $93,792
17,968 Added 78.41%
40,882 $164,000
Q1 2022

May 10, 2024
BUY
$4.83 - $7.35 $110,674 - $168,417
22,914 New
22,914 $113,000
Q1 2022

Jun 20, 2023
SELL
$4.83 - $7.35 $85,655 - $130,344
-17,734 Reduced 43.63%
22,914 $113,000
Q1 2022

Mar 22, 2023
SELL
$4.83 - $7.35 $26,521 - $40,358
-5,491 Reduced 19.33%
22,914 $113,000
Q1 2022

May 12, 2022
SELL
$4.83 - $7.35 $26,521 - $40,358
-5,491 Reduced 19.33%
22,914 $113,000
Q4 2021

May 17, 2024
BUY
$6.16 - $12.07 $50,653 - $99,251
8,223 Added 40.74%
28,405 $197,000
Q4 2021

Jun 21, 2023
SELL
$6.16 - $12.07 $75,416 - $147,773
-12,243 Reduced 30.12%
28,405 $197,000
Q4 2021

Mar 22, 2023
BUY
$6.16 - $12.07 $50,653 - $99,251
8,223 Added 40.74%
28,405 $197,000
Q4 2021

Feb 15, 2022
BUY
$6.16 - $12.07 $50,653 - $99,251
8,223 Added 40.74%
28,405 $198,000
Q3 2021

May 17, 2024
SELL
$9.7 - $14.34 $77,182 - $114,103
-7,957 Reduced 28.28%
20,182 $201,000
Q3 2021

Jun 21, 2023
SELL
$9.7 - $14.34 $198,520 - $293,482
-20,466 Reduced 50.35%
20,182 $201,000
Q3 2021

Mar 22, 2023
SELL
$9.7 - $14.34 $77,182 - $114,103
-7,957 Reduced 28.28%
20,182 $201,000
Q3 2021

Nov 15, 2021
SELL
$9.7 - $14.34 $77,182 - $114,103
-7,957 Reduced 28.28%
20,182 $202,000
Q2 2021

Jun 21, 2023
SELL
$13.43 - $19.16 $167,995 - $239,672
-12,509 Reduced 30.77%
28,139 $399,000
Q1 2021

May 17, 2024
SELL
$15.82 - $22.11 $493,489 - $689,699
-31,194 Reduced 52.57%
28,139 $461,000
Q1 2021

Jun 26, 2023
SELL
$15.82 - $22.11 $197,892 - $276,573
-12,509 Reduced 30.77%
28,139 $462 Million
Q1 2021

Mar 22, 2023
SELL
$15.82 - $22.11 $2,009 - $2,807
-127 Reduced 0.45%
28,139 $461,000
Q1 2021

May 14, 2021
SELL
$15.82 - $22.11 $2,009 - $2,807
-127 Reduced 0.45%
28,139 $462,000
Q4 2020

May 24, 2024
BUY
$7.91 - $22.95 $6,976 - $20,241
882 Added 3.22%
28,266 $585,000
Q4 2020

Jun 22, 2023
SELL
$7.91 - $22.95 $97,941 - $284,166
-12,382 Reduced 30.46%
28,266 $585,000
Q4 2020

Mar 22, 2023
BUY
$7.91 - $22.95 $6,976 - $20,241
882 Added 3.22%
28,266 $585,000
Q4 2020

Feb 16, 2021
BUY
$7.91 - $22.95 $6,976 - $20,241
882 Added 3.22%
28,266 $585,000
Q3 2020

May 24, 2024
BUY
$7.36 - $9.87 $47,067 - $63,118
6,395 Added 30.47%
27,384 $208 Million
Q3 2020

Jun 26, 2023
SELL
$7.36 - $9.87 $97,623 - $130,915
-13,264 Reduced 32.63%
27,384 $208,000
Q3 2020

Mar 22, 2023
BUY
$7.36 - $9.87 $47,067 - $63,118
6,395 Added 30.47%
27,384 $208,000
Q3 2020

Nov 13, 2020
BUY
$7.36 - $9.87 $47,067 - $63,118
6,395 Added 30.47%
27,384 $208,000
Q2 2020

May 24, 2024
SELL
$4.67 - $8.95 $179,066 - $343,178
-38,344 Reduced 64.63%
20,989 $175 Million
Q2 2020

Jun 26, 2023
SELL
$4.67 - $8.95 $91,807 - $175,948
-19,659 Reduced 48.36%
20,989 $174,000
Q1 2020

Jul 12, 2023
SELL
$3.95 - $7.4 $77,653 - $145,476
-19,659 Reduced 48.36%
20,989 $103,000
Q1 2020

Mar 22, 2023
SELL
$3.95 - $7.4 $23,233 - $43,526
-5,882 Reduced 21.89%
20,989 $103,000
Q1 2020

May 15, 2020
BUY
$3.95 - $7.4 $82,906 - $155,318
20,989 New
20,989 $104,000
Q3 2018

Nov 14, 2018
SELL
$5.42 - $6.99 $94,080 - $121,332
-17,358 Closed
0 $0
Q2 2018

Aug 15, 2018
BUY
$5.99 - $8.17 $103,974 - $141,814
17,358 New
17,358 $117,000

Others Institutions Holding OCUL

# of Institutions
189
Shares Held
132M
Call Options Held
374K
Put Options Held
179K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $560M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email